Cancer chemotherapy in young children: Challenges and solutions

Pediatric Blood and Cancer

Volumn 49, Issue 7 SUPPL., 2007, Pages 1091-1092

  Koren, Gideon ^a   Schechter, Tali ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Chemotherapy; Children; Infants

Indexed keywords

ANTINEOPLASTIC AGENT; CHLOROACETALDEHYDE; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOCHROME P450; CYTOCHROME P450 2B22; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DOXORUBICIN; IFOSFAMIDE; TENIPOSIDE; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; DISEASE SEVERITY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EFFICACY; DRUG ELIMINATION; DRUG METABOLISM; GLOMERULAR DYSFUNCTION; HUMAN; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOLID TUMOR; SWINE; TUBULAR DYSFUNCTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS;

EID: 35648971065     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21349     Document Type: Review

References (8)

1. Bjorkman S., Prediction of cytochrome P450-mediated hepatic drug clearance in neonates, infants and children: How accurate are available scaling methods? Clin Pharmacokinet 2006;45:1-11.
2. Chen N, Aleksa K, Woodland C, et al. Ontogeny of drug elimination by the human kidney. Pediatr Nephrol 2006;160-168.
3. McLeod HL, Relling MV, Crom WR, et al. Disposition of antineoplastic agents in the very young child. Br J Cancer 1992; 66:S23-S29.
4. Bleyer WA, Danielson MG. Oral cancer chemotherapy in paediatric patients: Obstacles and potential for development and utilization. Drugs 1999;3:133-140.
5. Frost BM, Eksborg S, Bjork O, et al. Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: Multiinstitutional collaborative study. Med Pediatr Oncol 2002; 38:329-337.
6. Crom WR, Glynn-Barnhart AM, Rodman JH, et al. Pharmacokinetics of anticancer drugs in children. Clin Pharmacokinet 1987;12: 168-213.
7. Yule SM, Boddy AV, Cole M, et al. Cyclophosphamide pharmacokinetics in children. Br J Clin Pharmacol 1996;41:13-19.
8. Aleksa K, Halachmi N, Ito S, Koren G. Renal ontogeny of ifosfamide nephrotoxicity. J Lab Clin Med 2004;144:285-293.